IMP3 contributes to poor prognosis of patients with metaplastic breast carcinoma: A clinicopathological study.
Sign Up to like & getrecommendations! Published in 2017 at "Annals of diagnostic pathology"
DOI: 10.1016/j.anndiagpath.2017.05.015
Abstract: Metaplastic breast carcinoma (MBC) is a rare type of tumor with heterogenous histological patterns. We investigated the immunohistochemical expression of IMP3, an oncofetal protein, in 31 MBC patients in association with histological subtypes and clinical… read more here.
Keywords: imp3 low; carcinoma; breast carcinoma; metaplastic breast ... See more keywords